The University of Washington and the University of California, Los Angeles have been approved to study PEX010 in clinical trials for mental health conditions VANCOUVER, BC, Aug. 8, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical-stage natural psychedelic drug development company, today announced approval from the United States Food…
